Поиск
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.

8. Список литературы

  1. Основы клинического питания. Материалы лекций для курсов Европейской ассоциации парентерального питания / Под ред. Л. Соботки: пер. с англ. – Москва, 2015. 751 с.
  2. Buchman AL, Scolapio J, Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology. 2003; 124:1111-1134.
  3. Mughal M, Irving M. Home parenteral nutrition in the United Kingdom and Ireland. Lancet. 1986; 2:383-387.
  4. Van Gossum A, Bakker H, Bozzetti F, et al. Home parenteral nutrition in adults: a European multicentre survey in 1997. ESPEN–Home Artificial Nutrition Working Group. Clin Nutr. 1999;18:135-140.
  5. Juana-Roa J, Wanden-Berghe C, Sanz-Valero J. [The reality of homebased parenteral nutrition in Spain]. Nutr Hosp. 2011; 26:364-368.
  6. Jeppesen PB. Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome. Therap Adv Gastroenterol. 2012; 5:159-171.
  7. Brandt CF, Bangsgaard L, Jess T, et al. The evolution of treatment of patients with intestinal failure with home parenteral nutrition. Gastroenterology. 2012;142:S613-S614.
  8. Энтеральное и парентеральное питание: национальное руководство / под ред. А. И Салтанова, Т. С. Поповой. - М. : ГЭОТАР-Медиа, 2014. - 814 с.
  9. Michael S. Short bowel syndrome: amelioration of diarrhea after vagotomy and pyloroplasty for peptic hemorrhage. Tohoku J Exp Med 2008; 214: 1: 7—10.
  10. Thompson J.S. Postoperative short bowel syndrome. J Am Coll Surg 2005; 201: 85—89.
  11. Donohoe C.L., Reynolds J.V. Short bowel syndrome. Surgeon 2010; 8:5: 270—279.
  12. Pironi L, Hebuterne X, Van Gossum A, et al. Candidates for intestinal transplantation: a multicenter survey in Europe. Am J Gastroenterol. 2006; 101:1633-1643; quiz 1679.
  13. Amiot A, Messing B, Corcos O, Panis Y, Joly F. Determinants of home parenteral nutrition dependence and survival of 268 patients with nonmalignant short bowel syndrome. Clin Nutr. 2013;32:368-374.
  14. Jeppesen P.B Spectrum of Short Bowel Syndrome in Adults: Intestinal Insufficiency to Intestinal Failure. Journal of Parenteral and Enteral Nutrition Volume 38 Supplement 1 May 2014 8S– 13S.
  15. Carbonnel F, Cosnes J, Chevret S, Beaugerie L, Ngoˆ Y, Malafosse M, et al. The role of anatomic factors in nutritional autonomy after extensive small bowel resection. J Parenter Enteral Nutr 1996;20:275–80.
  16. Баранская Е. К., Шульпекова Ю. О. Принципы ведения пациентов с синдромом короткого кишечника// Русский медицинский журнал: независимое издание для практикующих врачей. - 2010. - Том 18, N 13. — С. 789—794.
  17. Nightingale J.M. Woodward on behalf of the Small Bowel and Nutrition Committee of the British Society of Gastroenterology. Guidelines for management of patients with a short bowel. 2006;12.
  18. Shaffer J. Intestinal failure: definition and service development. Clin Nutr 2002;21(Suppl. 1):144e5.
  19. Thompson J.S., Weseman R., Rochling F.A., et al. Preresection BMI influences post resection BMI in short bowel syndrome. Medimind Int Proc 2009; 103-9.
  20. Thompson J.S., Weseman R., Rochling F.A., Mercer D.F. Current management of short bowel syndrome. Curr Probl Surg 2012; 49:52-115.
  21. Szczgiel B., Jonkers-Schuitema C., Naber T. Basics in Clinical Nutrition: Nutritonal support in extensive gut resections (short bowel) Eur e- J Clin Nutr Metab 2010; 5: e63-68.
  22. Kelly DG, Tappenden KA, Winkler MF. Short bowel syndrome: highlights of patient management, quality of life, and survival. JPEN J Parenter Enteral Nutr. 2014;38(4):427-437.
  23. Scolapio J.S. Short bowel syndrome. JPEN J Parenter Enteral Nutr 2002; 26:11-6.
  24. Nandivada P., Fell G.L., Gura K.M., Puder M. Lipid emulsions in the treatment and prevention of parenteral nutrition-associated liver disease in infants and children. Am. J. Clin. Nutr. 2016;103:629S–634S. doi: 10.3945/ajcn.114.103986.
  25. Wales P.W., Allen N., Worthington P., George D., Compher C., American Society for Parenteral and Enteral Nutrition. Teitelbaum D. A.S.P.E.N. clinical guidelines: Support of pediatric patients with intestinal failure at risk of parenteral nutrition-associated liver disease. J. Parenter. Enter. Nutr. 2014; 38:538–557. doi: 10.1177/0148607114527772.
  26. Kapoor V., Malviya M.N., Soul R. Lipid emulsion for parenterally fed term and late preterm infants. Cochrane Database Syst.Rev.2019, 2019:6.
  27. Caldarini M.I., Pons S., D’Agostino D. et al. Abnormal fecal flora in a patient with short bowel syndrome. An in vitro study on effect of pH on D-lactic acid production // Dig. Dis. Sci. - 1996. - Vol. 41, N 8. - P. 1649-1652.
  28. Руководство по клиническому питанию / под ред. В.М. Луфта. – СПб.: «Арт-Экспресс», 2016, 484 с.
  29. Соломенцева Т. А. Синдром короткой кишки: тактика врача-гастроэнтеролога. Острые и неотложные состояния в практике врача. — 2009. — № 5. — С. 50-55.
  30. Gennari FJ, Weise WJ. Acid-base disturbances in gastrointestinal disease.Clin J Am Soc Nephrol. 2008; 3:1861-1868.
  31. DuPont AW, Sellin JH. Ileostomy diarrhea. Curr Treat Options Gastroenterol 2006; 9:39–48.
  32. Sriram K, Lonchyna VA. Micronutrient supplementation in adult nutrition therapy: practical considerations. JPEN J Parenter Enteral Nutr.2009; 33:548-562.
  33. Pironi L, Arends J, Bozzetti F, Cuerda C et al. ESPEN guidelines on chronic intestinal failure in adults. Clinical Nutrition 35 (2016) 247-307 Clinical Nutrition 35 (2016) 247-307.
  34. Michael Staun, Loris Pironi, Federico Bozzetti Janet Baxter, Alastair Forbes et al. ESPEN Guidelines on Parenteral Nutrition: Home Parenteral Nutrition (HPN) in adult patients / Clinical Nutrition 28 (2009) 467–479.
  35. Eckerwall G., Andersson R. Early enteral nutrition in severe acute pancreatitis. Scand. J Gastroenteral. 2001. 5:449-457.
  36. Heyland D.K. Enteral and parenteral nutrition in the seriously ill, hospitalized patient: a critical review of the evidence. J Nutr. Helth & Aging, 2000 (1):31-41.
  37. A. Weimann , M. Braga, F. Carli et al. ESPEN guideline: Clinical nutrition in surgery .Clinical Nutrition 36,2017; 623:650.
  38. European Union of Medical Specialists (EUMS), Geriatric Medicine Section. Definition of geriatrics. http://uemsgeriatricmedicine.org/www/land/ definition/english.asp-1089. [Accessed 5 April 2018]
  39. Zhong, X.; Zhang, X.H.; Li, X.M.; Zhou, Y.M.; Li, W.; Huang, X.X.; Zhang, L.L.; Wang, T. Intestinal growth and morphology is associated with the increase in heat shock protein 70 expression in weaning piglets through supplementation with glutamine. J. Anim. Sci. 2011, 89, 3634–3642.
  40. Chen, S.; Xia, Y.; Zhu, G.; Yan, J.; Tan, C.; Deng, B.; Deng, J.; Yin, Y.; Ren, W. Glutamine supplementation improves intestinal cell proliferation and stem cell differentiation in weanling mice. Food Nutr. Res. 2018, 620.
  41. Wang B, Wu G, Zhou Z, Dai Z, Sun Y, Ji Y, et al. Glutamine and intestinal barrier function. Amino Acids 2015; 47(10): 2143–54.
  42. Ding LA, Li JS. Effects of glutamine on intestinal permeability and bacterial translocation in TPN- rats with endotoxemia. World J Gastroenterol. 2003 Jun;9(6):1327-32.
  43. Mingxiao GUO, Yousheng LI, Jieshou LI Effect of growth hormone, glutamine, and enteral nutrition on intestinal adaptation in patients with short bowel syndrome. Turk J Gastroenterol 2013; 24 (6): 463-468.
  44. Scolapio JS, McGreevy K, Tennyson GS, Burnett OL. Effect of glutamine in short-bowel syndrome. Clin Nutr 2001 Aug; 20(4):319-23].
  45. Справочник по клиническому питанию / под ред. В.М. Луфта. – СПб.: Росбалт, 2018, 362 с
  46. Луфт В.М., Багненко С.Ф., Щербук Ю.А., Луфт А.В. Энтеральное питание больных в интенсивной медицине – СПб.: ART-XPRESS, 2010. 179 с.
  47. Nightingale JM, Kamm MA, van der Sijp JR, Ghatei MA, Bloom SR, Lennard Jones JE. Gastrointestinal hormones in short bowel syndrome.Peptide YY may be the 'colonic brake' to gastric emptying. Gut 1996;39(2):267-72.
  48. McIntyre PB, Fitchew M, Lennard Jones JE. Patients with a high jejunostomydo not need a special diet. Gastroenterology 1986; 91(1):25-33.
  49. Levy E, Frileux P, Sandrucci S, Ollivier JM et al. Continuous enteral nutrition during the early adaptive stage of the short bowel syndrome. Br J Surg 1988;75(6):549-53.
  50. Cosnes J, Evard D, Beaugerie L, Gendre JP, Le Quintrec Y. Improvement in protein absorption with a small-peptide-based diet in patients with high jejunostomy. Nutrition 1992;8(6):406-11.
  51. Joly F, Dray X, Corcos O, Barbot L, Kapel N, Messing B. Tube feeding improves intestinal absorption in short bowel syndrome patients. Gastroenterology 2009 Mar;136(3):824-31.
  52. Forbes A. Challenges in treating intestinal failure and short bowel syndrome. ESPEN LLL Website, Module 12.2.
  53. Gabe SM, Shaffer JL, Forbes A, Holst M, Irtun O, Klek S, et al. The management of patients with high output enterocutaneous gastrointestinal fistulae: a European Survey. Clin Nutr 2012;7(Suppl. 1):14-5.
  54. Vanner S. The small intestinal bacterial overgrowth. Irritable bowel syndrome hypothesis: Implications for treatment. Gut. 2008;57:1315–21.
  55. Rana SV, Bhardwaj SB. Small intestinal bacterial overgrowth. Scand J Gastroenterol. 2008; 43:1030–7.
  56. Jeppesen PB, Christensen MS, Hoy CE, et al. Essential fatty acid deficiency in patients with severe fat malabsorption. Am J Clin Nutr 1997; 65:837–43.
  57. Nordgaard I, Hansen BS, Mortensen PB. Colon as a digestive organ in patients with short bowel. Lancet 1994; 343:373–6.
  58. Парфенов А.И. Энтерология – М.: ООО «Медицинской информационное агентство», 2008. 1100 с.
  59. Авдеев, В. Диагностика и лечение синдрома избыточного роста бактерий в тонкой кишке / В. Авдеев // Врач. – 2010. – № 12. – С. 1–3.
  60. Маев И. В. Диагностика и лечение синдрома избыточного бактериального роста в тонкой кишке / И. В. Маев, Н. Ю. Ивашкина, Ю. А. Кучерявый, Т. С. Оганесян // Экспер. клин. гастроэнтерол. – 2011. – № 3. – С. 125–129.
  61. Oren Zaidel, Uninvited Guests: The Impact of Small Intestinal Bacterial Overgrowth on Nutritional Status / Oren Zaidel, Henry C. Lin. // Practical Gastroenterology. – 2003. – Vol. XXVII (7). – P. 24–37.
  62. Gabrielli, M., G. D. Angelo, T. D. I. Rienzo, E. Scarpellini, V. Ojetti Diagnosis of small intestinal bacterial оvergrowth in the clinical practice // European Review for Medical and Pharmacological Sciences. – 2013. V.17. Р. 30–35.
  63. Бондаренко, В. М. Дисбактериоз кишечника как клинико-лабораторный синдром: современное состояние проблемы. Руководство для врачей / В. М. Бондаренко, Т. В. Мацулевич – М.: ГЭОТАР-Медиа, 2007. – 304 с.
  64. Ардатская, М. Д. Синдром избыточного бактериального роста: учебное пособие / М.: Форте Принт, 2011. – 56 с.
  65. Плотникова, Е. Ю. Некоторые аспекты диагностики и лечения избыточной бактериальной контаминации тонкой кишки в клинической практике [электронный ресурс] / Е. Ю. Плотникова, М. В. Борщ, М. В. Краснова, Е. Н. Баранова // Лечащий врач. – 2013. № 2. С 40-44.
  66. Lembo, A. Rifaximin for the treatment of diarrhea associated irritable bowel syndrome: short term treatment leading to long term sustained response / A. Lembo, S. F. Zakko, N. L. Ferreira // Gastroenterology. – 2008. – Vol. 134 (4, suppl. 1). – P. 545.
  67. Pimentel, M. Rifaximin therapy for patients with irritable bowel syndrome without constipation / M. Pimentel, A. Lembo, W. D. Chey // N. Engl. J. Med. – 2011. – Vol. 364. – P. 22–32.
  68. Nightingale JMD. The short bowel. In: Nightingale JMD, ed. Intestinal Failure. London, UK: Greenwich Medical Media; 2001:177-198.
  69. Parrish С.R. The Clinician’s Guide to Short Bowel Syndrome. Practical Gastroenterology, Sep. 2005, 67, p.67-106. 27.
  70. Маевская Е.А., Черёмушкин С.В., Кривобородова Н.А. и др. Синдром избыточного бактериального роста в тонкой кишке: от последних научных данных к рутинной практике // Клинические перспективы гастроэнтерологи, гепатологии . 2013. №5, С.29-40.
  71. Ардатская М.Д., Логинов В.А., Минушкин О.Н.Новые возможности диагностики и коррекции микроэкологических нарушений кишечника. Consilium medicum. Гастроэнтерология, 2013, 2: 51-58.
  72. Quigley EMM, Flourie B. Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date.Neurogastroenterol Motil, 2007, 19: 166–72.
  73. Uchida H, Yamamoto H, Kisaki Y, Fujino J, Ishimaru Y, Ikeda H. D-lactic acidosis in short-bowel syndrome managed with antibiotics and probiotics. J Pediatr Surg Actions 2004 Apr; 39(4):634- 6. doi: 10.1016/j.jpedsurg.2003.12.026..
  74. Kunz AN, Noel JM, Fairchok MP. Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J Pediatr Gastroenterol Nutr 2004 Apr; 38(4):457e8.
  75. De Groote MA, Frank DN, Dowell E, Glode MP, Pace NR. Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J 2005 Mar; 24(3):278-80.
  76. Reddy VS, Patole SK, Rao S. Role of probiotics in short bowel syndrome in infants and children: systematic review. Nutrients 2013 Mar 5; 5(3):679e99. http://dx.doi.org/10.3390/nu5030679. Review. PubMed PMID:23462584.
  77. Shenderov B. A. Metabiotics: novel idea or natural development of probiotic conception // Microb. Ecol. Health Dis. 2013. Vol. 24. Р. 203–299.
  78. Nightingale JMD, Lennard-Jones JE, Walker ER, et al. Oral salt supplements to compensate for jejunostomy losses: comparison of sodium chloride capsules, glucose electrolyte solution and glucose polymer electrolyte solution (Maxijul). Gut 1992; 33:759–61.
  79. Лейдерман И.Н., Ярошецкий А.И., Кокарев Е.А., Мазурок В.А. Парентеральное питание. Вопросы и ответы. Руководство для врачей. СПб-Онли Пресс. 2016. 192 с.
  80. Pironi L, Arends J, Baxter J, Bozzetti F. et al. ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults. Clin Nutr 2015 Apr;34(2):171e80. http://dx.doi.org/10.1016/ j.clnu. 2014.08.017. PubMed PMID: 25311444.
  81. Crenn P, Coudray-Lucas C, Thuillier F, Cynober L, Messing B. Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology. 2000; 119:1496-1505.
  82. Pironi L, Joly F, Forbes A, et al. Long-term follow-up of patients on home parenteral nutrition in Europe: implications for intestinal transplantation. Gut. 2011; 60:17-25.
  83. Barnadas G. Navigating home care: parenteral nutrition—part two. Pract Gastroenterol. 2003; 27:13-30.
  84. Kelly DG. The clinician’s responsibility for the consumer’s financial wellbeing. Nutr Clin Pract. 2006; 21:539-541.
  85. Mascioli EA, Lopes SM, Champagne C, Driscoll DF. Essential fatty acid deficiency and home total parenteral nutrition patients. Nutrition 1996; 12:245–9.
  86. Jeppesen PB, Hoy CE, Mortensen PB. Differences in essential fatty acid requirements by enteral and parenteral routes of administration in patients with fat malabsorption. Am J Clin Nutr 1999; 70:78–84.
  87. Jeppesen PB, Hoy CE, Mortensen PB. Deficiencies of essential fatty acids, vitamin A and E and changes in plasma lipoproteins in patients with reduced fat absorption or intestinal failure. Eur J Clin Nutr 2000; 54:632–42.
  88. Nutritional Risk, Micronutrient Status and Clinical Outcomes: A Prospective Observational Study in an Infectious Disease Clinic / O. S. Dizdar, O. Baspınar, D. Kocer, et al. // Nutrients. 2016. №8 (3). — Р. 124.
  89. Quigley EM, Quera R, Abu-Shanab A, editors. The Enteric Flora in Intestinal Failure: Small Intestinal Bacterial Overgrowth and Gut-Derived Sepsis. Malden: Blackwell Publishing; 2008.
  90. Hornsby-Lewis L, Shike M, Brown P, Klang M, Pearlstone D, Brennan MF. L glutamine supplementation in home total parenteral nutrition patients: stability, safety, and effects on intestinal absorption. J Parenter Enter Nutr 1994;18(3):268-73.
  91. Culkin A, Gabe S, Bjarnason I, Grimble G, Madden AM, Forbes A. A double-blind, randomized, controlled crossover trial of glutamine supplementation in home parenteral nutrition. Eur J Clin Nutr 2008; 62:575-83.
  92. Novak F, Heyland DK, Avenell A, Drover JW, Su X. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med 2002; 130:2022-9.
  93. Fusaro F1, Hermans D, Wanty C, Veyckemans F, Pirenne J, Reding R. Post-serial transverse enteroplasty bowel redilatation treated by longitudinal intestinal lengthening and tailoring procedure. J Pediatr Surg. 2012 Oct; 47(10):e19-22.
  94. D’Antiga L., Goulet O. Intestinal failure in children: The European view. J. Pediatr. Gastroenterol. Nutr. 2013;56:118–126. doi: 10.1097/MPG.0b013e318268a9e3.
  95. Kapoor V., Malviya M.N., Soul R. Lipid emulsion for parenterally fed term and late preterm infants. Cochrane Database Syst.Rev.2019, 2019:6.
  96. Helmrath M.A., Fong J.J., Dekaney C.M., et al. Rapid expansion of intestinal secretory lineages following amassive small bowel resection in mice. Am J Physiol Gastrointest Liver Physiol 2007; 292:215-22.
  97. Carbonnel F, Cosnes J, Chevret S, Beaugerie L, Ngo Y, Malafosse M, et al. The role of anatomic factors in nutritional autonomy after extensive small bowel resection. JPEN J Parenter Enteral Nutr 1996;20:275–80.
  98. Jeppesen P.B. et al. Short bowel patients treated for two years with glucagon-like peptide 2 (GLP- 2): compliance, safety, and effects on quality of life. Gastroenterol Res Pract 2009.
  99. Jeppesen PB, Sanguinetti EL, Buchman A, et al. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut 2005; 54:1224–31.
  100. Jeppesen P.B., Pertkiewicz M., Forbes , Pironi L. et al. Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide e Analyses from a randomised, placebo-controlled study.Clinical Nutrition 32 (2013) 713-721.
  101. Iyer K, et al. Long-Term Safety and Efficacy With Teduglutide Treatment in Patients With Intestinal Failure Associated With Short Bowel Syndrome (SBS–IF): The STEPS-3 Study. Poster presented at the 36th European Society for Clinical Nutrition and Metabolism Congress; September 6–9, 2014; Geneva, Switzerland.
  102. Schwartz STEPS ACG-2 Final Results 2013 Poster, Poster Number: P171 (021-STEPS2
  103. Byrne_TA, Wilmore_DW, Iyer_K, Dibaise_J, Clancy_K et al. Growth hormone, glutamine, and an optimal diet reduces parenteral nutrition in patients with short bowel syndrome:a prospective, randomized, placebo-controlled, double-blindclinical trial. Ann Surg 2005; 242(5):655-61. [PUBMED: 16244538]
  104. Yun Chen, Ya-Hui Tai, Bor-Jiun Tseng, Sheng-Hong Тseng Influence of Growth Hormone and Glutamine on Intestinal Stem Cells: A Narrative Review, 2019; 17;11(8):1941.
  105. Shanbhogue LKR, Molenaar JC. Short bowel syndrome: metabolic and surgical management. Br J Surg 1994; 81:486–99.
  106. Thompson JS. Surgery for patients with a short bowel. In: Nightingale JMD,eds. Intestinal failure. Greenwich: Greenwich Medical Media Limited, 2001:515–27.
  107. Barry Jones, Christine Holden, Rebecca Stratton et al. Artificial nutrition support in the UK, 2005. (Published on BAPEN website in 2006): www.bapen.org.uk ISBN 1 899 467 11 4
  108. Broviac JW, Cole JJ, Scribner BH. A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet 1973; 136:602–6.
  109. Hickman RO, Buckner CD, Clift RA, Sanders JE, Stewart P, Thomas ED. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet 1979; 148:871–5.
  110. Howard L, Claunch C, McDowell R, Timchalk M. Five years of experience in patients receiving home nutrition support with the implanted reservoir: a comparison with the external catheter. JPEN J Parenter Enteral Nutr 1989; 13:478–83.
  111. Kuizon D, Gordon SM, Dolmatch BL. Single-lumen subcutaneous ports inserted by interventional radiologists in patients undergoing chemotherapy: incidence of infection and outcome of attempted catheter salvage. Arch Intern Med 2001; 161:406–10.
  112. McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med 2003; 348:1123–33.
  113. Cotogni P, Pittiruti M, Barbero C, Monge T, Palmo A, Boggio Bertinet D. Catheter-related complications in cancer patients on home parenteral nutrition: a prospective study of over 51,000 catheter days. J Parenter Enter Nutr 2013; 37:375e83.
  114. Cowl CT, Weinstock JV, Al-Jurf A, Ephgrave K, Murray JA, Dillon K. Complications and cost associated with parenteral nutrition delivered to hospitalized patients through either subclavian or peripherally-inserted central catheters. Clin Nutr 2000; 19:237–43.
  115. Verso M, Agnelli G, Kamphuisen PW, Ageno W, Bazzan M, Lazzaro A, et al. Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients. Intern Emerg Med 2008; 3:117-22.
  116. Cadman A, Lawrance JA, Fitzsimmons L, Spencer-Shaw A, Swindell R. To clot or not to clot? That is the question in central venous catheters. Clin Radio2004; 59(4):349-55.
  117. O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al.Healthcare infection control practices advisory committee. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 2011; 39(Suppl. 1):S1-4.
  118. Профилактика катетер-ассоциированных инфекций кровотока и уход за центральным венозным катетером / Клинические рекомендации, МЗ РФ. 2017. 43 с.
  119. Randolph AG, Cook DJ, Gonzales CA, Andrew M. Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomized controlled trials. Br Med J 1998; 316:969-75.
  120. Goode CJ, Titler M, Rakel B, Ones DS, Kleiber C, Small S, et al. A meta-analysis of effects of heparin flush and saline flush: quality and cost implications. Nurs Res 1991; 40:324-30.
  121. Capdevila JA, Gavald_a J, Fortea J, L_opez P, Martin MT, Gomis X, et al. Lack of antimicrobial activity of sodium heparin for treating experimental catheterrelated infection due to Staphylococcus aureus using the antibiotic-lock technique. Clin Microbiol Infect 2001; 7:206-12.
  122. Shanks RM, Donegan NP, Graber ML, Buckingham SE, Zegans ME, Cheung AL,et al. Heparin stimulates staphylococcus aureus biofilm formation. Infect Immun 2005;73:4596-606.
  123. Goossens GA, J_er^ome M, Janssens C, Peetermans WE, Fieuws S, Moons P, et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Ann Oncol 2013; 24:1892-9.
  124. Wouters Y., Erna Causevic E., Klek S., Groenewoud H., Wanten G. Use of Catheter Lock Solutions in Patients Receiving Home Parenteral Nutrition: A Systematic Review and Individual- Patient Data Meta- analysis. American Society for Parenteral and Enteral Nutrition. Journal of Parenteral and Enteral Nutrition. 2020 Sep; 44(7):1198-1209.
  125. Ch. Shah, M. Wittelmann, J.W. Costerton, et al. Antimicrobial activity of a new solution for closing the catheter. - Antimicrobial Agents and Chemotherapy, June 2002, 1674-1679.
  126. Siri Tribler et all. Taurolidine-citrate-heparin lock reduces catheter-related bloodstream infections in intestinal failure patients dependent on home parenteral support: a randomized, placebo-controlled trial - Am J Clin Nutr 2017; 106:839–48.
  127. Kursat Gundogan, Nisha J. Dave, Daniel P. Griffith and al. Ethanol Lock Therapy Markedly Reduces Catheter-Related Blood Stream Infections in Adults Requiring Home Parenteral Nutrition: A Retrospective Study From a Tertiary Medical Center, Journal of Parenteral and Enteral Nutrition. 2019;00; 1–7.
  128. Tingting Zhao , Hong Liu , Jibin Han Ethanol lock is effective on reducing the incidence of tunneled catheter‑related bloodstream infections in hemodialysis patients:a systematic review and meta‑analysis - International Urology and Nephrology, https://doi.org/10.1007/s11255-018-1855- 4, 26 March 2018.
  129. Wengler A, Micklewright A, Heґbuterne X, Bozzetti F, Pertkiewicz M, Moreno J,et al. Home parenteral nutrition teaching practice in Europe. Clin Nutr 2002:21–42.
  130. ASPEN Board of Directors and the Clinical Guidelines Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr 2002; 26(Suppl. 1):1SA–138SA.
  131. Newton A.F., DeLegge M.H. Home initiation of parenteral nutrition. Nutr Clin Pract 2007; 22:57–64.
  132. Smith CE, Curtas S, Werkowitch M, Kleinbeck SV, Howard L. Home parenteral nutrition: does affiliation with a national support and educational organization improve patient outcomes? JPEN J Parenter Enteral Nutr 2002; 26:159–63.
  133. Santarpia L, Pasanisi F, Alfonsi L, Violante G, Tiseo D et al. Prevention and treatment of implanted central venous catheter (CVC) – related sepsis: a report after six years of home parenteral nutrition (HPN). Clin Nutr 2002; 21:207–11.
  134. Kovacevich D, Corrigan M, Ross V.M. et al American Society for Parenteral and Enteral Nutrition Guidelines for the Selection and Care of Central Venous Access Devices for Adult Home Parenteral Nutrition Administration Journal of Parenteral and Enteral Nutrition Vol 43, Num 1 , 2019, 15–31.
  135. Rege AS, Sudan DL. Autologous gastrointestinal reconstruction: review of the optimal nontransplant surgical options for adults and children with short bowel syndrome. Nutr Clin Pract. 2013 Feb; 28(1):65-74.
  136. Abu-Elmagd K.M., Armanyous SR , Fujiki M. et al. Management of Five Hundred Patients With Gut Failure at a Single Center: Surgical Innovation Versus Transplantation With a Novel Predictive Model Ann Surg. 2019 Oct;270(4):656-674.
  137. Gondolesi GE , Doeyo M , Lic CE et al. Results of Surgical and Medical Rehabilitation for Adult Patients With Type III Intestinal Failure in a Comprehensive Unit Today: Building a New Model to Predict Parenteral Nutrition Independency JPEN J Parenter Enteral Nutr. 2020 May; 44(4):703-713.
  138. Khan FA, Squires RH, Litman HJ, et al. Predictors of enteral autonomy in children with intestinal failure: a multicenter cohort study. J Pediatr. 2015; 167:29–34.
  139. Gabriel E Gondolesi , Mariana Doeyo , Constanza Echevarria Lic , Fernando Lobos , Santiago Rubio , Carolina Rumbo et al. Results of Surgical and Medical Rehabilitation for Adult Patients With Type III Intestinal Failure in a Comprehensive Unit Today: Building a New Model to Predict Parenteral Nutrition Independency JPEN J Parenter Enteral Nutr. 2020 May; 44(4):703-713.
  140. Rege A. The Surgical Approach to Short Bowel Syndrome - Autologous Reconstruction versus Transplantation.Viszeralmedizin. 2014 Jun; 30(3):179-89.
  141. Kareem M Abu-Elmagd , Sherif R Armanyous , Masato Fujiki , Neha R Parekh , Mohammed Osman , Marissa Scalish , Elizabeth Newhouse , Yasser Fouda et al. Management of Five Hundred Patients With Gut Failure at a Single Center: Surgical Innovation Versus Transplantation With a Novel Predictive Model Ann Surg. 2019 Oct;270(4):656-674.
  142. Kareem M Abu-Elmagd , Guilherme Costa, David McMichael, Ajai Khanna, Ruy J Cruz et al. Autologous Reconstruction and Visceral Transplantation for Management of Patients With Gut Failure After Bariatric Surgery: 20 Years of Experience Ann Surg. 2015 Oct;262(4):586-601.
  143. Allan PJ, Stevens P, Abraham A, Paine P, Farrer K, Teubner A, Carlson G, Lal S. Outcome of intestinal failure after bariatric surgery: experience from a national UK referral centre. Eur J Clin Nutr. 2016 Jul;70(7):772-8.
  144. Sudan D, Thompson J, Botha J, Grant W, Antonson D, Raynor S, Langnas A Comparison of intestinal lengthening procedures for patients with short bowel syndrome..Ann Surg. 2007 Oct; 246(4):593-601.
  145. Kelly DG, Tappenden KA, Winkler MF. Short bowel syndrome: highlights of patient management, quality of life, and survival. JPEN J Parenter Enteral Nutr. 2014 May;38(4):427-37.
  146. Rodríguez Iglesias P, Domènech Tárreg AB, Driller C, Mangas Álvarez L, Vila Carbó JJ. Efficacy of the intestinal rehabilitation program in patients with short bowel syndrome. Cir Pediatr. 2019 Apr 22;32(2):74-80.
  147. Gabriel Ramos-Gonzalez , Heung Bae Kim. Autologous intestinal reconstruction surgery. Semin Pediatr Surg. 2018 Aug; 27(4):261-266.
  148. Frongia G, Kessler M, Weih S, Nickkholgh A, Mehrabi A, Holland-Cunz S. Comparison of LILT and STEP procedures in children with short bowel syndrome -- a systematic review of the literature. J Pediatr Surg. 2013 Aug;48(8):1794-805.
  149. Shah AA, Petrosyan M, Franklin AL, Chahine AA, Torres C, Sandler AD. Autologous intestinal reconstruction: a single institution study of the serial transverse enteroplasty (STEP) and the longitudinal intestinal lengthening and tailoring (LILT). Pediatr Surg Int. 2019 Jun;35(6):649-655.
  150. Jones BA, Hull MA, Potanos KM, etal. Report of 111consecutivepatientsenrolled in the International Serial Transverse Enteroplasty (STEP) Data Registry: a retrospective observational study. J Am Coll Surg. 2013; 216:438–446.
  151. Belza C, Wales PW. Multidisciplinary Management in Pediatric Ultrashort Bowel Syndrome. J Multidiscip Healthc. 2020 Jan 9; 13:9-17.
  152. Brian A Jones, Melissa A Hull, Heung Bae Kim. Autologous intestinal reconstruction surgery for intestinal failure management. Curr Opin Organ Transplant. 2010 Jun;15(3):341-5.
  153. Mikko P Pakarinen , Annika Kurvinen, Antti I Koivusalo, Tarja Iber, Risto J Rintala. Long-term controlled outcomes after autologous intestinal reconstruction surgery in treatment of severe short bowel syndrome. J Pediatr Surg. 2013 Feb; 48(2):339-44.]
  154. Pironi L, Konrad D, Brandt C et al. Clinical classification of adult patients with chronic intestinal failure due to benign disease: an international multicenter cross-sectional survey. Clin Nutr. 2018;37:728–738.
  155. Chungfat N, Dixler I, Cohran V, et al. Impact of parenteral nutrition-associated liver disease on intestinal transplant waitlist dynamics. J Am Coll Surg 2007; 205:755.
  156. Vianna R, Fridell JA, Mangus R, et al. Safe inclusion of the entire pancreas as a component of the multivisceral graft. Transplantation 2008; 86:114.
  157. Wu G, Selvaggi G, Nishida S, et al. Graft-versus-host disease after intestinal and multivisceral transplantation. Transplantation 2011; 91:219.
  158. Abu-Elmagd KM. Intestinal transplantation for short bowel syndrome and gastrointestinal failure: current consensus, rewarding outcomes, and practical guidelines. Gastroenterology 2006; 130:S132.
  159. Iyer KR, Iverson AK, DeVoll-Zabrocki A, et al. Pediatric intestinal transplantation-- review of current practice. Nutr Clin Pract 2002; 17:350.
  160. Fiel MI, Sauter B, Wu HS, et al. Regression of hepatic fibrosis after intestinal transplantation in total parenteral nutrition liver disease. Clin Gastroenterol Hepatol 2008; 6:926.
  161. Nightingal J., Woodward J.M. et al. – Guidelines for management of patients with a short bowel. – Gut, 2006:55(Suppl.4), iv1 – iv12; J.K.DiBase, J.Rosemary Young – Intestinal Rheabilitation and the Short Bowel Syndrome: Part 2.- Am.J.of Gastrroenterology. – 2004, N99: 1823 – 1832.
  162. American gastroenterological Association medical position statement: Short bowel syndrome and intestinal transplantation. – Gastroenterology,2019, Vol.4(N4), p.1105-1110].

Для продолжения работы требуется Регистрация
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
8. Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Оглавление

Данный блок поддерживает скрол*